MapLight Therapeutics, Inc. Common Stock (MPLT) is a publicly traded the market company. As of July 18, 2026, MPLT trades at $37.70 with a market cap of $1.69B and a P/E ratio of -2.01. MPLT moved +1.96% today. Year to date, MPLT is +115.60%; over the trailing twelve months it is flat. Its 52-week range spans $12.24 to $40.43. Analyst consensus is strong buy with an average price target of $41.56. Rallies surfaces MPLT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks MPLT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $37.70 |
| Market Cap | $1.69B |
| P/E Ratio | -2.01 |
| EPS | $-18.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.43 |
| 52-Week Low | $12.24 |
| Volume | 726.55K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-161.15M |
| Gross Margin | 0.00% |
10 analysts cover MPLT: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.56.